Cocrystal Pharma Inc

COCP

Company Profile

  • Business description

    Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

  • Contact

    19805 North Creek Parkway
    BothellWA98011
    USA

    T: +1 877 262-7123

    E: [email protected]

    https://www.cocrystalpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    11

Stocks News & Analysis

stocks

Eagers international foray

Our view on CanadaOne acquisition.
stocks

Tesla: Shares down despite record deliveries

We think the positive third-quarter numbers will be largely offset by a weak fourth quarter.
stocks

ASX listed share dominates their industry

Shares are currently fairly valued with a Wide Moat rating.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,240.3042.600.46%
CAC 408,056.6389.681.13%
DAX 4024,422.56308.941.28%
Dow JONES (US)46,564.60123.500.27%
FTSE 1009,427.7318.70-0.20%
HKSE27,287.12431.561.61%
NASDAQ22,847.8192.650.41%
Nikkei 22544,936.73385.880.87%
NZX 50 Index13,451.7617.770.13%
S&P 5006,719.438.230.12%
S&P/ASX 2008,945.9040.100.45%
SSE Composite Index3,882.7820.250.52%

Market Movers